Comparison of Assisted Reproductive Technology (ART) Outcomes in Two Controlled Ovarian Stimulation Protocols Using Follitropin Delta, a Recombinant Follicle-Stimulating Hormone (rFSH) Injection
While previous studies have indicated that no significant differences in outcomes between these protocols, the present study observed that the follitropin delta enhanced the formation of blastocysts and good-quality blastocysts. Further research is needed to determine whether these findings are specific to follitropin delta or extend to other recombinant follicle-stimulating hormone (rFSH) preparations.
Authors
- Hiroaki Shibahara (ORCID: https://orcid.org/0000-0001-7966-3170)
- Kohyu Furuhashi (ORCID: https://orcid.org/0000-0002-5511-1205)
- Masahide Shiotani (ORCID: https://orcid.org/0000-0001-9159-944X)
- Noritoshi Enatsu (ORCID: https://orcid.org/0000-0002-9375-5191)
- Eri Okamoto
- Shoji Kokeguchi
- Kazuki Yamagami (ORCID: https://orcid.org/0000-0002-5734-9057)
Institutions
- Kobe Women's University (JP)
- Department of Embryology (US)
Publication Details
- Journal
- Cureus
- Published
- 2025-03-27
- DOI
- https://doi.org/10.7759/cureus.81281
- Citations
- 1
- Primary Topic
- Ovarian function and disorders
- Type
- article
- Field-Weighted Citation Impact
- 1.70